Download PDF
Frauenheilkunde up2date 2009; 3(3): 175-195
DOI: 10.1055/s-0029-1224514
Geburtshilfe und Perinatalmedizin

© Georg Thieme Verlag KG Stuttgart ˙ New York

Eklampsie und HELLP-Syndrom[1]

G. Knichwitz, W. Klockenbusch
Further Information

Publication History

Publication Date:
29 June 2009 (online)

Also available at
    Permissions and Reprints All articles of this category

Einleitung

Die Inzidenz und der Stellenwert der schwangerschaftsbedingten Erkrankungen (Gestosen) unterscheiden sich nach Region und Entwicklung des Gesundheitssystems erheblich. Die Müttersterblichkeit liegt nach Angaben der WHO in westlichen Ländern bei 1 : 4 000, in Asien bei 1 : 132 und in Afrika bei 1 : 19. Weltweit sind etwa 60 000 Frauen pro Jahr betroffen [65].

Die hierfür in den Industrienationen hauptsächlich verantwortlichen schwangerschaftsbedingten Erkrankungen sind insbesondere die hypertensiven Erkrankungen mit ihren schweren Komplikationen

schwere Präeklampsie, Eklampsie und HELLP-Syndrom.

Die Terminologie dieser Erkrankungen ist bis heute noch uneinheitlich, da die Ätiologie weiterhin unklar ist. Im folgenden Text werden die schwangerschaftsinduzierte Hypertonie, die Präeklampsie, die Eklampsie und das HELLP-Syndrom aufgrund ihrer ätiologischen Gemeinsamkeiten zusammen besprochen.

1 Mod. nach Erstpublikation in Intensivmedizin up2date 2008; 4: 113–133

Literatur

  • 1 American College of Obstetricians and Gynecologists. Hypertension in pregnancy The Committee on Terminology of the American College of Obstetricians and Gynecologists. Washington, DC.  Am Coll Obstet Gynecol. 1996;  53 175-183
    Search in Google Scholar
  • 2 American CoOaG. 77: ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002.  Int J Gyn Obstet. 2002;  77 67-75
    Search in Google Scholar
  • 3 Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy.  Am J Obstet Gynecol. 1982;  142 159-167
    Search in Google Scholar
  • 4 National High Blood Pressure Education Program Working Group . Report on high blood pressure in pregnancy.  Am J Obst Gynecol. 1990;  163 1689-1712
    Search in Google Scholar
  • 5 Cook D J, Sibbald W J, Vincent J -L et al. Evidence based critical care medicine: what is it and what can it do for us?.  Crit Care Med. 1996;  24 334-337
    CrossrefSearch in Google Scholar
  • 6 Afifi Y, Churchill D. Pharmacological treatment of hypertension in pregnancy.  Curr Pharm Des. 2003;  9 1745-1753
    CrossrefSearch in Google Scholar
  • 7 Sibai B M. Diagnosis and management of gestational hypertension and preclampsia.  Obstet Gynecol. 2003;  102 181-192
    CrossrefSearch in Google Scholar
  • 8 Welsch H, Krone H A. Mütterliche Mortalität bei HELLP-Syndrom in Bayern 1983–1992.  Zentralbl Gynäkol. 1994;  116 202-206
    Search in Google Scholar
  • 9 Sibai B M, Caritis S N, Thom E et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women.  N Engl J Med. 1993;  329 1213-1218
    CrossrefPubMedSearch in Google Scholar
  • 10 CLASP. A randomised trial of low dose aspirin for the prevention and treatment of pre-eclampsia among 9 364 pregnant women.  Lancet. 1994;  343 619-629
    CrossrefSearch in Google Scholar
  • 11 Douglas K A, Redman C WG. Eclampsia in the United Kingdom.  Brit Med J. 1994;  309 1395-1400
    Search in Google Scholar
  • 12 Sibai B M. Eclampsia – VI. Maternal – perinatal outcome in 254 consecutive cases.  Am J Obstet Gynecol. 1990;  163 1049-1055
    Search in Google Scholar
  • 13 Rath W. Agressives versus konservatives Vorgehen beim HELLP-Syndrom – eine Standortbestimmung.  Geburtsh Frauenheilk. 1996;  56 265-271
    Thieme ConnectSearch in Google Scholar
  • 14 Reubinoff B E, Schenker J G. HELLP syndrome – a syndrome of hemolysis, elevated liver enzymes and low platelet count – complicating preeclampsia-eclampsia.  Int J Gynecol Obstet. 1991;  36 95-102
    CrossrefSearch in Google Scholar
  • 15 Sibai B M, Ramadan M K, Usta I et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome).  Am J Obstet Gynecol. 1993;  169 1000-1006
    CrossrefSearch in Google Scholar
  • 16 Boxer L M, Malinow A M. Pre-eclampsia and eclampsia.  Current Opin Anaesthesiol. 1997;  10 188-198
    CrossrefSearch in Google Scholar
  • 17 Roberts J M, Cooper D W. Pathogenesis and genetics of preeclampsia.  Lancet. 2001;  357 53-56
    CrossrefSearch in Google Scholar
  • 18 Sibai B M, Gordon T, Thom E et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study.  Am J Obstet Gynecol. 1995;  172 642-648
    CrossrefSearch in Google Scholar
  • 19 Stone J L, Lockwood C J, Berkowitz G S et al. Risk factors for severe preeclampsia.  Obstet Gynecol. 1994;  83 357-361
    Search in Google Scholar
  • 20 Dekker G A, Van Geijn H P. Endothelial dysfunction in preeclampsia. Part I: Primary prevention. Therapeutic perspectives.  J Perinatol Med. 1996;  24 99-117
    Search in Google Scholar
  • 21 Frey L. Gestose und HELLP-Syndrom.  Anaesthesist. 1997;  46 732-747
    CrossrefSearch in Google Scholar
  • 22 Knichwitz G, Louwen F. Intensivmedizin in der Schwangerschaft. In: Van Aken H, Reinhart K, Zimpfer M, Hrsg. Intensivmedizin. Stuttgart, New York: Thieme; 2001: 1299–1313
  • 23 Knichwitz G, Prien T. Intensivmedizinische Aspekte bei Präeklampsie – Eklampsie.  Anästhesiol Intensivmed Notfallmed Schmerzther. 1991;  26 342-346
    Thieme ConnectSearch in Google Scholar
  • 24 Ballegeer V C, Spitz B, De Baene L A et al. Platelet activation and vascular damage in gestational hypertension.  Am J Obstet Gynecol. 1992;  166 629-633
    Search in Google Scholar
  • 25 Friedman S A, De Groot C JM, Taylor R N et al. Plasma cellular fibronectin as a measure of endothelial involvement in preeclampsia and intrauterine growth retardation.  Am J Obstet Gynecol. 1994;  170 838-841
    Search in Google Scholar
  • 26 Davidge S T, Signorella A P, Hubel C A et al. Distinct factors in plasma of preeclamptic women increase endothelial nitric oxide or prostacyclin.  Hypertension. 1996;  28 758-764
    Search in Google Scholar
  • 27 Tsukimori K, Maeda H, Shingu M et al. Possible mechanism of vascular damage in pre-eclampsia.  J Human Hypertension. 1994;  8 177-180
    Search in Google Scholar
  • 28 Friedman S A. Preeclampsia: a review of the role of prostaglandins.  Obstet Gynecol. 1988;  71 122-137
    Search in Google Scholar
  • 29 Davidge S T, Hubel C A, Brayden R D et al. Sera antioxidant activity in uncomplicated and preeclamptic pregnancies.  Obstet Gynecol. 1992;  79 897-901
    Search in Google Scholar
  • 30 Wang Y, Walsh S W, Guo J, Zhang J. The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood.  Am J Obstet Gynecol. 1991;  165 1695-1700
    Search in Google Scholar
  • 31 Mastrogiannis D S, O'Brian W F, Krammer J et al. Potential role of endothelin-1 in normal and hypertensive pregnancies.  Am J Obstet Gynecol. 1991;  165 1711-1716
    Search in Google Scholar
  • 32 Myatt L, Brewer A S, Langdon G et al. Attenuation of vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation.  Am J Obstet Gynecol. 1992;  166 224-230
    Search in Google Scholar
  • 33 Brown M A, Zammit V C, Mitar D M. Extracellular fluid volumes in pregnancy-induced hypertension.  J Hypertension. 1992;  10 61-68
    CrossrefSearch in Google Scholar
  • 34 Hays P M, Cruikshank D P, Dunn L J. Plasma volume determination in normal and preeclamptic pregnancies.  Am J Obstet Gynecol. 1985;  151 985-966
    Search in Google Scholar
  • 35 Mushambi M C, Halligan A W, Williamson K. Recent developments in the pathophysiology and management of pre-eclampsia.  Brit J Anaesth. 1996;  76 133-148
    Search in Google Scholar
  • 36 Visser W, Wallenburg H CS. Central hemodynamic observation in untreated preeclamptic patients.  Hypertension. 1991;  17 1072-1077
    Search in Google Scholar
  • 37 Royburt M, Seidman D, Serr D et al. Neurologic involvement in hypertensive disease of pregnancy.  Obstet Gynecol. 1991;  46 656-661
    Search in Google Scholar
  • 38 Seidman D S, Sen D M, Ben-Rafael Z. Renal and ocular manifestations of hypertensive diseases of pregnancy.  Obstet Gynecol. 1991;  46 71-78
    Search in Google Scholar
  • 39 Sibai B M, Mabie B C, Harvey C J et al. Pulmonary edema in severe preeclampsia-eclampsia: Analysis of thirty-seven consecutive cases.  Am J Obstet Gynecol. 1987;  156 1174-1179
    CrossrefSearch in Google Scholar
  • 40 Desai D K, Moodley J, Naidoo D P et al. Cardiac abnormalities in pulmonary oedema associated with hypertensive crises in pregnancy.  Brit J Obstet Gynaecol. 1996;  103 523-528
    Search in Google Scholar
  • 41 Schiff E, Friedman S A, Kao L et al. The importance of urinary protein excretion during conservative management of severe preeclampsia.  Am J Obstet Gynecol. 1996;  175 1313-1316
    CrossrefSearch in Google Scholar
  • 42 Chua S, Redman C W. Prognosis for pre-eclampsia complicated by 5 g or more of proteinuria in 24 hours.  Eur J Obstet Gynecol Reprod Biol. 1992;  43 9-12
    CrossrefSearch in Google Scholar
  • 43 Wolf J L. Liver desease in pregnancy.  Med Clin North Am. 1996;  80 1167-1187
    Search in Google Scholar
  • 44 Salfelder A, Kagerah M, Nugent W et al. Diagnostische Probleme beim HELLP-Syndrom – dargestellt anhand von 20 Fallbeispielen.  Zentralbl Gynäkol. 1993;  115 433-445
    Search in Google Scholar
  • 45 Rath W, Loos W, Kuhn W. Diagnostische und therapeutische Probleme beim HELLP-Syndrom.  Z Geburtsh Perinatol. 1992;  196 185-192
    Search in Google Scholar
  • 46 Wilke G, Rath W, Schutz E et al. Haptoglobin as a sensitive marker of hemolysis in HELLP-syndrome.  Int J Gynecol Obstet. 1992;  39 29-34
    CrossrefSearch in Google Scholar
  • 47 Rath W, Loos W, Graeff H et al. Das HELLP-Syndrom.  Gynäkologe. 1992;  25 430-440
    Search in Google Scholar
  • 48 Martin J N, Blake P G, Perry K G et al. The natural history of HELLP syndrome: patterns of disease progression and regression.  Am J Obstet Gynecol. 1991;  164 1500-1513
    CrossrefPubMedSearch in Google Scholar
  • 49 Knox T A, Olans L B. Liver disease in pregnancy.  N Engl J Med. 1996;  335 569-576
    CrossrefSearch in Google Scholar
  • 50 Schwartz M L, Lien J M. Spontaneous liver hematoma in pregnancy not clearly associated with preeclampsia: A case presentation and literature review.  Am J Obstet Gynecol. 1997;  176 1328-1333
    CrossrefSearch in Google Scholar
  • 51 Neiger R, Contag S A, Coustan D R. The resolution of preeclampsia-related thrombocytopenia.  Obstet Gynecol. 1991;  77 692-695
    Search in Google Scholar
  • 52 Rath W, Wieding J U, Kuhn W. Neue Erkenntnisse über hämostasiologische Veränderungen bei Gestose und HELLP-Syndrom für die klinische Praxis.  Geburtsh Frauenheilk. 1991;  51 741-746
    Thieme ConnectSearch in Google Scholar
  • 53 Nolan T E, Wakefield M L, Devoe L D. Invasive hemodynamic monitoring in obstetrics. A critical review of its indications, benefits, complications, and alternatives.  Chest. 1992;  101 1429-1433
    CrossrefSearch in Google Scholar
  • 54 Sibai B M, Mercer B M, Schiff E et al. Aggressive versus expectant management of severe preeclampsia at 28 to 32 weeks gestation: a randomized controlled trial.  Am J Obstet Gynecol. 1994;  171 818-822
    CrossrefPubMedSearch in Google Scholar
  • 55 Visser W, Wallenburg H CS. Temporising management of severe pre-eclampsia with and without the HELLP-syndrome.  Brit J Obstet Gynaecol. 1995;  102 111-117
    Search in Google Scholar
  • 56 Toppozada M K. Role of prostaglandins in pre-eclampsia.  Acta obstet gynecol scand. 1990;  69 375-377
    CrossrefSearch in Google Scholar
  • 57 Fox J G, Sutcliffe N P, Walker J J et al. Postpartum eclampsia and acut renal failure: treatment with prostacyclin. Case report.  Brit J Obstet Gynaecol. 1991;  98 400-402
    Search in Google Scholar
  • 58 Beaufils M, Uzan S, Donsimoni R et al. Prevention of preeclampsia by early antiplatelet therapy.  Lancet. 1985;  1 840-842
    Search in Google Scholar
  • 59 Wallenburg H CS, Dekker G A, Makovitz J W et al. Low-dose-aspirin prevents pregnancy induced hypertension and preeclampsia in angiotensin sensitive primigravidae.  Lancet. 1986;  1 1-3
    Search in Google Scholar
  • 60 Benedetti T J, Kates R, Williams V. Hemodynamic observations in severe preeclampsia complicated by pulmonary edema.  Am J Obstet Gynecol. 1985;  152 330-334
    Search in Google Scholar
  • 61 Friedman S A, Kee-Hak L, Baker C A et al. Phenytoin versus magnesium sulphate in pre-eclampsia: a pilot study.  Am J Perinatol. 1993;  10 233-238
    Thieme ConnectSearch in Google Scholar
  • 62 The ETCG. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial.  Lancet. 1995;  345 1455-1463
    Search in Google Scholar
  • 63 Sibai B M. Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia.  Am J Obstet Gynecol. 1990;  162 1141-1145
    Search in Google Scholar
  • 64 Sibai B M. Diagnosis and management of gestational hypertension and preeclampsia.  Obstet Gynecol. 2003;  102 181-192
    CrossrefSearch in Google Scholar
  • 65 Hill K. Making deaths count.  Bull World Health Organ. 2006;  84 162
    CrossrefSearch in Google Scholar
  • 66 Duley L, Henderson-Smart D J, Meher S et al. Antiplatelet agents for preventing preeclampsia and its complications. Cochrane Database Syst Rev 2007; 2: CD004659
  • 67 Duley L, Henderson-Smart D J, Meher S et al. Antiplatelet agents for preventing preeclampsia and its complications. Cochrane Database Syst Rev 2007; 18: CD004659
  • 68 Ganzevoort W, Rep A, Bonsel G J et al. A randomised controlled trial comparing two temporising management strategies, one with and one without plasma volume expansion, for severe and early onset pre-eclampsia.  Brit J Obstet Gynaecol. 2005;  112 1358-1368
    CrossrefSearch in Google Scholar
  • 69 The Magpie Trial Collaborative Group . Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial. A randomised, placebo-controlled trial.  Lancet. 2002;  359 1877-1890
    CrossrefSearch in Google Scholar
  • 70 Magee L, Miremadi S, Li J et al. Therapy with both magnesium sulphate and nifedipine does not increase the risk of serious magnesium-related maternal side-effects in women with preeclampsia.  Am J Obstet Gynecol. 2005;  193 153-163
    CrossrefSearch in Google Scholar
  • 71 Magee L A, Cham C, Waterman E J et al. Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis.  Brit Med J. 2003;  327 955-960
    CrossrefSearch in Google Scholar
  • 72 Duley L, Galmezoglu A M, Henderson-Smart D J. Magnesium sulfate and other anticonvulsants for women with preeclampsia. Cochrane Database Syst Rev 2003; 2: CD000025

1 Mod. nach Erstpublikation in Intensivmedizin up2date 2008; 4: 113–133

Prof. Dr. med. G. Knichwitz

Abteilung für Anästhesiologie, Intensivmedizin und Schmerztherapie Malteser-Krankenhaus Bonn/Rhein-Sieg

Von-Hompesch-Str. 1

53123 Bonn

Email: knichwi@uni-muenster.de


Weiterführende Literatur
AWMF-Leitlinien-Register Nr. 015 / 018.
www.leitlinien.net